It has been used widely to treat other fibrotic ... patients with early chronic disease to receive either 400 mg sustained-release pentoxifylline or placebo twice daily for 6 months.
A double-blind, randomized, six-month study by Roekaerts and Deleers [39] assessed the efficacy and safety of pentoxifylline 400 mg three times daily versus placebo in 36 patients with IC.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback